CE Activities Archive - RMEI

Climbing the Ladder to Optimal Outcomes in NTM-LD: Navigating a Clear Path from Diagnosis Thru Treatment

0.5 CE Credit(s)

Halting the Vicious Vortex: Targeting Neutrophil Serine Protease Activation in Non-Cystic Fibrosis Bronchiectasis (NCFBE)

0.25 CE Credit(s)

Tackling Treatment-Refractory and Drug-Resistant CMV in the Solid Organ Transplant Setting: A Care Team Forum®

0.75 CE Credit(s)

Optimizing Biologic Therapy in Children with Moderate-to-Severe Atopic Dermatitis: A Care Team Forum®

1.0 CE Credit(s)

Halting the Vicious Vortex: Case-based Discussions in Non-Cystic Fibrosis Bronchiectasis

0.5 CE Credit(s)

Updates in Hereditary Angioedema Care from HAEA

1.0 CE Credit(s)

Quelling the Vicious Vortex: Targeting Neutrophil Serine Proteases in Non-Cystic Fibrosis Bronchiectasis

COMING SOON

Navigating the Frontier of Hematologic Malignancy Therapies. Series of 5 Modules

3.00 CE Credit(s)

Cell-Free DNA Potential in Guiding Therapies and Q&A – Module 5

1.00 CE Credit(s)

PROTACs: A Paradigm Shift in Drug Discovery – Module 3

0.50 CE Credit(s)

Novel ADC Target Hunting in Pediatric AML – Module 4

0.50 CE Credit(s)

Approaches Beyond Classic CAR T-Cells – Module 2

0.50 CE Credit(s)

Bispecific Antibodies Latch Onto Advances – Module 1

0.50 CE Credit(s)

Tackling the Barriers to the Accurate Diagnosis and Optimal Management of Bipolar Depression

0.5 CE Credit(s)

Incorporating New Therapies to Hone the Treatment of Resistant or Refractory CMV in the Post-SOT Setting

REGISTER TO ATTEND

Stronger for Longer: Managing Chronic Active ABMR in Renal Allograft Recipients

1.0 CE Credit(s)

Taking Stock of the Evolving Treatment Landscape for Acute GvHD in HSCT: Proceedings from a Clinical Olympics℠

1.00 CE Credit(s)

Exploiting BCMA in the Treatment of Multiple Myeloma: How Could Bispecific Antibodies and T-Cell Engagement Impact Relapsed/Refractory Disease? Proceedings from a Clinical Olympics℠

1.0 CE Credit(s)

What Lies Beneath: Current and Emerging Treatments for Prurigo Nodularis

0.50 CE Credit(s)

Immunotherapy in NMSC: Challenges in CSCC and BCC

0.25 CE Credit(s)

Reducing the Burden and Improving QoL in Non-Cystic Fibrosis Bronchiectasis: A Team-Based Approach to Challenging Cases

0.25 CE Credit(s)

Reducing the Burden and Improving QoL in Non-Cystic Fibrosis Bronchiectasis: Insights on Challenging Cases

0.25 CE Credit(s)

Virtual IBD Clinic: Surgical and Pharmacological Therapeutics

0.75 CE Credit(s)

Virtual IBD Clinic: Updates in Diagnostic, Therapeutic, and Prognostic Strategies

0.75 CE Credit(s)

Save Their Breath: Diagnosing and Treating NTM-LD

0.25 CE Credit(s)

Assessing Potential Implications of New Data on CMV Treatment in Transplant Recipients

0.50 CE Credit(s)

What Lies Beneath: Diagnostic Challenges of Prurigo Nodularis

0.50 CE Credit(s)

New Insights into the Pathophysiology and Treatment of Non-Cystic Fibrosis Bronchiectasis

0.50 CE Credit(s)

Antiviral Therapies in Pediatric Influenza: What Does the Current Data Say?

0.25 CE Credit(s)

Breath-Taking Stories: A Discussion of Real-World Cases of NTM-LD

0.50 CE Credit(s)

Immunotherapy in NMSC: Bringing the Data to Life

0.50 CE Credit(s)

Optimal Management of Nontuberculous Mycobacterial Lung Disease: A Clinical Olympics Proceedings

1.00 CE Credit(s)

Creating a Pathway to Identify and Treat Influenza in Pediatric Patients

0.50 CE Credit(s)

Utilizing a CDST for Resistant/Refractory CMV in Hematopoietic Cell Transplant Patients

0.5 CE Credit(s)

Case-based Discussion on the Interprofessional Management of Non-Motor Symptoms in Patients with Parkinson’s Disease

0.50 CE Credit(s)

Harnessing the Full Potential of Frontline Immunotherapy in Advanced NSCLC: Proceedings from a Clinical Olympics℠

1.0 CE Credit(s)

Current and Emerging Therapies for Acute Graft-vs-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

0.50 CE Credit(s)

Optimizing Treatment of Resistant/Refractory CMV Infection in Solid Organ Transplant Recipients

0.75 CE Credit(s)

Challenging Cases in Asthma: Improving Quality of Life (3 of 3)

0.25 CE Credit(s)

Challenging Cases in Asthma: Optimizing Biologics in Adults (2 of 3)

0.25 CE Credit(s)

Utilizing a CDST for Resistant/Refractory CMV in Solid Organ Transplant Patients

0.50 CE Credit(s)

Antibody-Mediated Rejection in Renal Transplantation: Immune Mechanisms, Diagnostic Criteria, & Therapeutic Advances: A Clinical Olympics℠

0.75 CE Credit(s)

Reinforcing the Roles of Biologic Therapy and Interprofessional Care in Improving Patient Outcomes (1 of 3)

0.25 CE Credit(s)

Patient-Centered Thinking and Achieving Optimal Outcomes in Patients with UC: A Care Team Forum®

1.00 CE Credit(s)

Practical Considerations for Recognizing, Diagnosing, and Managing Non-Cystic Fibrosis Bronchiectasis: A Care Team Forum®

1.00 CE Credit(s)

Seeing Nonmelanoma Skin Cancers Through a New Lens: The Role and Place of Immunotherapy

1.00 CE Credit(s)

Deciphering the Root Cause of Chronic Active Antibody-Mediated Rejection in Renal Transplant

0.50 CE Credit(s)

Getting it Right in Crohn’s Disease: A Clinical Guideline and Decision Tool-Based Approach (part 2 of 2)

0.25 CE Credit(s)

Assessing the Potential Implications of New Data in Chronic Spontaneous Urticaria

0.25 CE Credit(s)

Nonmelanoma Skin Cancers, Immunotherapies, and Role of Dermatology Clinicians: A Care Team Forum^®

0.75 CE Credit(s)

The Road to Cures Series: COVID-19, Vaccinations, and Blood Cancer Patients: The LLS Registry and Q&A – Module 5 of 5

0.75 CE Credit(s)

The Road to Cures Series: Novel Therapeutic Strategies in Myeloma – Module 4 of 5

0.50 CE Credit(s)

The Road to Cures Series: Efficacy of Targeted Therapy in Genetic Subtypes of Aggressive Lymphoma – Module 3 of 5

0.50 CE Credit(s)

The Road to Cures Series: AML 2021: Strategies for Attack Before Diagnosis and After Remission – Module 2 of 5

0.50 CE Credit(s)

The Road to Cures Series: CAR-T Therapy: What’s in the CARds? – Module 1 of 5

0.50 CE Credit(s)

Challenging Cases of Severe COVID-19: Unlikely Patients and Breakthrough Infections

0.25 CE Credit(s)

Challenging Cases of Severe COVID-19: Managing High Risk and Unvaccinated Patients

0.25 CE Credit(s)

EXPIRES: April 5, 2023

Perspectives on Optimizing Immunotherapy in Advanced BCC and CSCC

0.50 CE Credit(s)

EXPIRES: April 5, 2023

Challenging Cases: HPI Switching in BCC, Adjuvant Therapy in CSCC

0.25 CE Credit(s)

EXPIRES: April 5, 2023

Challenging Cases: BCC in HIV Infection, New Skin Lesions in Metastatic CSCC

0.25 CE Credit(s)

When Small Steps are GIANT LEAPS: Treating Spinal Muscular Atrophy

0.50 CE Credit(s)

Managing Severe COVID-19 in the Hospital Setting: An Interprofessional Approach

0.50 CE Credit(s)

Targeting Pathophysiologic Pathways in Cervical Cancer: Why Immunotherapy?

0.25 CE Credit(s)

Meeting the Challenges of IBD Management in the Era of COVID-19: A Panel Case Review & Discussion

0.50 CE Credit(s)

Crohn’s Disease: Targets, Risk Stratification, and Clinical Tools: A Care Team Forum

1.00 CE Credit(s)

Improving Outcomes in NTM-LD: Identifying Risk Factors and Applying New Guidelines to Practice

1.00 CE Credit(s)

Improving the Treatment of Chronic Spontaneous Urticaria: What Does the Future Hold?

0.50 CE Credit(s)

Targeting EGFR Exon 20 Insertions in NSCLC: Current and Future Prospects

0.75 CE Credit(s)

The Evolving Role of Orexin-Based Therapy in Narcolepsy Type 1 Management

0.75 CE Credit(s)

Immunotherapy in Cervical Cancer: What’s New?

0.25 CE Credit(s)

Overcoming Diagnostic Barriers in Chronic Spontaneous Urticaria

0.25 CE Credit(s)

Challenging Cases in NTM-LD: Treating Refractory MAC and Mitigating Adverse Events

0.25 CE Credit(s)

Challenging Cases in NTM-LD: Refractory MAC and Medication Intolerance

0.25 CE Credit(s)

Improving Outcomes in NTM-LD: Strategies for Diagnosis, Personalized Care, and Interprofessional Management

0.50 CE Credit(s)

Challenging Cases in Atopic Dermatitis: Managing Pediatric Patients and Adults with Multiple Comorbidities

0.25 CE Credit(s)

Challenging Cases in Atopic Dermatitis: Managing Patients with Comorbid Asthma

0.25 CE Credit(s)

On the Frontline: Immunotherapeutic Approaches in Advanced NSCLC

0.75 CE Credit(s)

CMV Perils in Transplant Recipients: Prevention, Resistance, and Safety Considerations

0.75 CE Credit(s)

Challenges and Opportunities with Checkpoint Inhibition for First-Line Management of Advanced NSCLC: A Care Team Forum℠

0.75 CE Credit(s)

Influenza in High-Risk Patients: Aching for Optimal Treatment

0.50 CE Credit(s)

Influenza Postexposure Prophylaxis: Don’t Overlook the High-Risk Patient

0.25 CE Credit(s)

Virtual IBD Clinic: Disease Management and Surgery

CE Credit Expired

Assessing the Potential Patient Care Implications of New Data in Eosinophilic Esophagitis: Clinical Transfers®

0.50 CE Credit(s)

Clearing the Path for the Accurate Diagnosis and Optimal Treatment of Bipolar Depression: A Clinical Convergence^®

0.75 CE Credit(s)

Overcoming Hurdles to Optimal Care for Patients with NTM-LD

0.50 CE Credit(s)

Targeting EGFR Exon 20 Insertions in NSCLC: Current and Future Prospects

1.00 CE Credit(s)

Challenges and Opportunities with Checkpoint Inhibition for First-Line Management of Advanced NSCLC

1.00 CE Credit(s)

A Guide to Expediting the Recognition & Diagnosis of NTM-LD

0.25 CE Credit(s)

Empowered Crohn’s Disease Care: Targets, Tools, and Talking to Patients

0.75 CE Credit(s)

Realizing the Promise of Interprofessional Care in Multiple Sclerosis

CE Credit Expired

Role of the Interprofessional Care Team in the Management of Non-Motor Symptoms in Parkinson’s Disease

CE Credit Expired

Redefining the Management of CMV in SOT: Emerging Options for High-Risk Patients: A Care Team Forum

0.75 CE Credit(s)

Frontline Checkpoint Inhibitor Monotherapy in NSCLC

0.25 CE Credit(s)

Understanding Checkpoint Inhibitors in NSCLC

0.25 CE Credit(s)

Basal Cell Carcinoma: To Targeted Therapy and Beyond—High-Risk Basal Cell Carcinoma: Navigating Treatment and Complications

0.25 CE Credit(s)

Clinical Convergence^®: Changing Perspectives—Fine Tuning Treatment for the Relapsed Refractory Patient with Chronic Myeloid Leukemia

0.75 CE Credit(s)

Insights on the Basal Cell Carcinoma Treatment Paradigm: Current Standards of Care and Emerging Approaches: A Care Team Forum^℠

0.75 CE Credit(s)

The HER Family: A Pan Tumor Approach: A Clinical Forum^℠

1.00 CE Credit(s)

Taking Stock of Current Options and Emerging Approaches for the Management of EoE

0.50 CE Credit(s)

Clinical Reflections^®Nonmelanoma Skin Cancers: Real-World Perspectives on Individualizing Care—Case Challenges in NMSC Management

0.50 CE Credit(s)

Copyright © 2023. RMEI Medical Education, LLC. All rights reserved

Privacy | Terms of Use